Other news to note

Auxilium Pharmaceuticals Inc., of Chesterbrook, Pa., said the U.S. District Court for the District of Delaware granted a motion from Upsher-Smith Laboratories Inc., of Maple Grove, Minn., for a summary judgment with respect to its attempts to bring a testosterone gel product to market via the 505(b)(2) pathway using Auxilium’s Testim product as its reference drug.